Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction

---
identifier: "/us/fr/2017-05417"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2017-05417"
section_name: "Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction"
positive_law: false
currency: "2017-03-20"
last_updated: "2017-03-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-05417"
document_type: "notice"
publication_date: "2017-03-20"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "82 FR 14366"
fr_volume: 82
docket_ids:
  - "Docket No. FDA-2016-N-0001"
fr_action: "Notice of public workshop; correction."
---


#  Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice of public workshop; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of Thursday, December 29, 2016. The document announced a  public workshop entitled “Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products.” The document was published with an error in the Web site address to access the transcript of the workshop. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Monica Kapoor, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 3111C, Silver Spring, MD 20993, *[email protected];* or Staci Revette, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 3109B, Silver Spring, MD 20993, *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of Thursday, December 29, 2016, in FR Doc. 2016-31628, on page 96008, the following correction is made:

On page 96008, in the second column under the *Transcripts* caption of section III, *Participating in the Public Workshop,* the third sentence in the fourth paragraph is corrected to read, “Please be advised that as soon as a transcript of the public workshop is available, it will be accessible at: *http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm525001.htm.* ”

Dated: March 14, 2017.

Leslie Kux,

Associate Commissioner for Policy.